30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Arch Therapeutics Inc (ARTH)

Stock chart
Ticker: ARTH Exchange: OTC


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hicks Laurence
1 purchase — total 2,830 USD
Buy 31 Aug 2023
Value US$1,939,397.88 | Price 468.43 | Shares 39,027
Buy 31 Aug 2023
Value US$1,858,794.00 | Price 270.10 | Shares 51,925
Buy 31 Aug 2023
Value US$2,830.30 | Price 0.28 | Shares 10,292
Buy 26 May 2016
Value US$0.00 | Price 0.00 | Shares 111,111
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-09-08 2023-08-31 B Purchase Non-Executive Director
39,027 -43.5%
468.43
US$1,939,398
39,027 -43.5% 468.43 US$1,939,398
2023-09-08 2023-08-31 B Purchase

PRESIDENT AND CHIEF EXECUTIVE

Executive Director
51,925 +47.8%
270.10
US$1,858,794
51,925 +47.8% 270.10 US$1,858,794
2023-09-08 2023-08-31 B Purchase

CHIEF FINANCIAL OFFICER

Officer
81,923 -44.2%
60.09
US$3,886,809
81,923 -44.2% 60.09 US$3,886,809
2016-05-31 2016-05-26 B Purchase SULAT JAMES R Non-Executive Director
111,111
0.00
US$0
111,111 0.00 US$0